Ann: OIL March 2024 Quarterly Report and Appendix 4C, page-15

First 15 Last

Share
Profile

Follow
BuffettWarren

1,557 Posts.

164

30/04/24

20:07

Post #: 73593347
Share

Originally posted by whytee: ↑

Well there are a lot ot irons in the fire right now. I don't think they can negotiate their way through the maze for all of this without the experts they have appointed and the consultants they've hired to help with the FDA. Sometimes you don't really understand what needs to be done until you start tackiling the problems and the steps become clearer as you break it down. I get the feeling that things will become clearer as they start working out exactly what the FDA wants and how to achieve it. I don't think you can blame the company for this, the rules have changed and they've seen new ways to unlock the potential. It's just how things have evolved.

Expand

Agree. I'm not putting any negativity towards the company at all (except my dig at the wording on the evaluation of our - as I see it - underperforming distributors).

Simply trying to put some guesswork into the timing of the InVivage getting to market. But as you said, the company has foreseen the enormity of the job of getting approvals for all the devices and put what appears excellent people in the States to maximise success and efficiency for the FDA process. They can't know yet how long the Invivage process is going to take, but my guess is again, it will not be till 2026 with the setback with fluorescein.

OIL Price at posting: 8.9¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply